Skip to main content
. 2020 Jun;20(2):549–559. doi: 10.4314/ahs.v20i2.2

Table 3.

Percentage drug resistance for nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)

Resistance level
(%)
Low Intermediate High Susceptible
Lamivudine 4.8 0 95.2 0
Abacavir 47.6 9.5 42.9 0
Zidovudine 4.8 0 42.9 52.4
Stavudine 9.5 0 42.9 47.6
Didanosine 47.6 9.5 42.9 0
Emtricitabine 4.8 0 95.2 0
Tenofovir 9.5 14.6 28.6 47.6